PCSK9 Inhibitors and Cardiovascular Events

Letter/Communication

Open access

Jennifer G Robinson and John J P Kastelein

The New England journal of medicine, Vol.373(8), pp.773-774

08/20/2015

DOI: 10.1056/NEJMc1508222

PMID: 26287854

Files and links (1)

url

https://pure.amsterdamumc.nl/ws/files/166930679/Pcsk9-inhibitors-and-cardiovascular-events-reply.pdfView

Open Access

Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage

Anticholesteremic Agents - therapeutic use

Cardiovascular Diseases - prevention & control

Humans

Antibodies, Monoclonal - therapeutic use

Cholesterol, LDL - blood

Female

Male

Hypercholesterolemia - drug therapy

Title: Subtitle: PCSK9 Inhibitors and Cardiovascular Events
Creators: Jennifer G Robinson
John J P Kastelein
Resource Type: Letter/Communication
Publication Details: The New England journal of medicine, Vol.373(8), pp.773-774
DOI: 10.1056/NEJMc1508222
PMID: 26287854
NLM abbreviation: N Engl J Med
eISSN: 1533-4406
Publisher: United States
Language: English
Date published: 08/20/2015
Academic Unit: Epidemiology; Internal Medicine
Record Identifier: 9983995014502771

22 Record Views